Patient with typical carcinoid initially diagnosed as high-grade neuroendocrine carcinoma

por Warsch, Sean, Jahanzeb, Mohammad
Publicado 2017

Response to Abemaciclib After 10 Lines of Therapy Including Palbociclib in Metastatic Breast Cancer: A Case Report With Literature Review

por Wender, Isabella O., Haines, Kayla, Jahanzeb, Mohammad
Publicado 2020

Patterns of occurrence and implications of neratinib-associated diarrhea in patients with HER2-positive breast cancer: analyses from the randomized phase III ExteNET trial

por Mortimer, Joanne, Di Palma, Jack, Schmid, Kendra, Ye, Yining, Jahanzeb, Mohammad
Publicado 2019

Does Race Affect Outcomes in Triple Negative Breast Cancer?

por Sachdev, Jasgit C., Ahmed, Saira, Mirza, Muhammad M., Farooq, Aamer, Kronish, Lori, Jahanzeb, Mohammad
Publicado 2010

Improving Quality of Cancer Care by Participating in Quality Oncology Practice Initiative Certification Program

por Jazieh, Abdul Rahman, Abdelhafiez, Nafisa, Al Mutairi, Nashmia, Hashem, Ahmed, Alkaiyat, Mohammad, Al Shami, Mona, Jahanzeb, Mohammad
Publicado 2020

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer...

por Tripathy, Debu, Rugo, Hope S, Kaufman, Peter A, Swain, Sandra, O’Shaughnessy, Joyce, Jahanzeb, Mohammad, Mason, Ginny, Beattie, Mary, Yoo, Bongin, Lai, Catherine, Masaquel, Anthony, Hurvitz, Sara
Publicado 2014

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States

por Jahanzeb, Mohammad, Lin, Huamao M, Wu, Yanyu, Zhang, Pingkuan, Gorritz, Magdaliz, McGuiness, Catherine B, Huang, Wei-Ti, Sun, Kainan, Chen, Chi-Chang, Camidge, D Ross
Publicado 2022

De Novo Versus Recurrent HER2‐Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

por Tripathy, Debu, Brufsky, Adam, Cobleigh, Melody, Jahanzeb, Mohammad, Kaufman, Peter A., Mason, Ginny, O'Shaughnessy, Joyce, Rugo, Hope S., Swain, Sandra M., Yardley, Denise A., Chu, Laura, Li, Haocheng, Antao, Vincent, Hurvitz, Sara A.
Publicado 2019

Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer

por Park, Wungki, Mezquita, Laura, Okabe, Naoyuki, Chae, Young Kwang, Kwon, Deukwoo, Saravia, Diana, Auclin, Edouard, Planchard, David, Caramella, Caroline, Ferrara, Roberto, Agte, Sarita, Oh, Michael, Mudad, Raja, Jahanzeb, Mohammad, Suzuki, Hiroyuki, Besse, Benjamin, Lopes, Gilberto
Publicado 2019

International Perspective on the Pursuit of Quality in Cancer Care: Global Application of QOPI and QOPI Certification

por Blayney, Douglas W., Albdelhafeez, Nafisa, Jazieh, Abdul Rahman, Pinto, Carlos Frederico, Udrea, Adrian, Roach, Alex, Das, Devika, Grubbs, Stephen, Hamm, John, Jahanzeb, Mohammad, Kamal, Arif H., Kelly, Ronan J., Martin, S. Eric, O'Mahony, Deirdre, Birch, Walter, Bowman, Ronda, Crist, Stéphanie T. S., Evers, Amy, Gilmore, Terry, Klein, Meredith, Siegel, Robert
Publicado 2020

Multi‐omic molecular profiling guide’s efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial

por Pierobon, Mariaelena, Robert, Nicholas J., Northfelt, Donald W., Jahanzeb, Mohammad, Wong, Shukmei, Hodge, Kimberly A., Baldelli, Elisa, Aldrich, Jessica, Craig, David W., Liotta, Lance A., Avramovic, Sanja, Wojtusiak, Janusz, Alemi, Farrokh, Wulfkuhle, Julia D., Bellos, Angela, Gallagher, Rosa I., Arguello, David, Conrad, Amber, Kemkes, Ariane, Loesch, David M., Vocila, Linda, Dunetz, Bryant, Carpten, John D., Petricoin, Emanuel F., Anthony, Stephen P.
Publicado 2021